Cary, NC, United States of America

David Renwick Houck

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 1.5

ph-index = 5

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2007-2013

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David Renwick Houck

Introduction

David Renwick Houck is a distinguished inventor based in Cary, NC, who has made significant strides in the field of ophthalmology and pharmaceutical formulations. With a total of eight patents to his name, Houck's inventions pertain to innovative methods and compounds that have implications for treating ocular disorders.

Latest Patents

Houck's recent work includes a patent concerning methods for the treatment and prevention of ocular disorders. This patent encompasses the administration of compounds formulated to address various ocular diseases, utilizing a specific structural formula as defined in his specification. Additionally, he has developed macrocyclic compounds that are disclosed in another patent, which have potential applications as pharmaceuticals, further showcasing his impact on medical research and treatment modalities.

Career Highlights

Currently, Houck is an integral part of Scynexis, Inc., a company known for its dedication to the discovery and development of innovative biopharmaceuticals. His contributions through the patents have empowered the company to enhance its therapeutic offerings in the healthcare market, thereby improving patient care and treatment outcomes.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues, including Hans Georg Fliri and Andrew Scribner. These partnerships have fostered a collaborative environment for innovation and have played a vital role in the progression of his research initiatives, leading to groundbreaking advancements in the field.

Conclusion

David Renwick Houck exemplifies the spirit of innovation through his impactful contributions to drug development and ocular health. With a proven track record of patents, he continues to push the boundaries of medical science, paving the way for new therapeutic approaches. His work not only enhances the understanding of ocular disorders but also contributes to a greater effective treatment landscape for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…